Amlodipine inhibits thapsigargin-sensitive Ca2+ stores in thrombin-stimulated vascular smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 279, Issue 3 48-3, 2000, Pages

  Stepien, Olivier ^a   Marche, Pierre ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Calcium channel blockers; Calcium mobilization; Vascular smooth muscle cell growth

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); AMLODIPINE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; DILTIAZEM; ISRADIPINE; THAPSIGARGIN; THROMBIN; VERAPAMIL;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

EID: 0033827082     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.279.3.h1220     Document Type: Article

References (43)

1. Thrombin signal transduction mechanisms in rat vascular smooth muscle cells
2. Thrombin-stimulated events in cultured vascular smooth muscle cells
3. 2+ channel
4. Effect of the new calcium antagonist lercanidipine and its enantiomers on the migration and proliferation of arterial myocytes
5. The effect of L-type calcium channel modulators on the mobilization of intracellular calcium stores in guinea-pig intestinal smooth muscle
6. Thrombin and proliferation of vascular smooth muscle cells
7. Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile
8. Short-term exposure to thapsigargin inhibits neointima formation in human saphenous vein
9. Persistent intracellular calcium pool depletion by thapsigargin and its influence on cell growth
10. L-type calcium channel expression depends on the differentiated state of vascular smooth muscle cells
11. 2+ indicators with greatly improved fluorescent properties
12. Characterization of the thrombin-induced contraction of vascular smooth muscle
13. Control of vascular smooth muscle cell growth by macrophage colony-stimulating factor
14. 2+]
15. Calcium channels in vascular smooth muscle cells
16. Multiple pathways for entry of calcium and other divalent cations in a vascular smooth muscle cell line A7r5
17. 2+ concentration without production of nitric oxide and von Willebrand factor
18. Pharmacology of smooth muscle cell replication
19. 2+ pool
20. Effects of sarcoplasmic reticulum calcium inhibitors on vascular smooth muscle
21. 2+-ATPase regulation
22. Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine
23. Vasodilatory action of amlodipine on rat aorta, pig coronary artery, human coronary artery, and on isolated Langendorff rat heart preparations
24. Thrombin and vascular smooth muscle cell proliferation: Implications for atherosclerosis and restenosis
25. 2+ release of separate quanta
26. 2+ channels
27. Stimulation of calcium entry is a prerequisite for DNA synthesis induced by platelet-derived growth factor in vascular smooth muscle cells
28. Selective interaction of the calcium antagonist amlodipine with calcium channel in arteries of spontaneously hypertensive rats
29. 2+ mobilization in vascular smooth muscle utilizes a slow ribosylating pertussis toxin-sensitive G protein
30. 2+ channels
31. The pathogenesis of atherosclerosis: A perspective for the 1990s
32. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers
33. Thapsigargin inhibits voltage-activated calcium channels in adrenal glomerulosa cells
34. A therapeutic dosage of amlodipine prevents vascular hyporeactivity induced in rats by lipopolysaccharide
35. 2+ pool content is linked to control of cell growth
36. Short-term exposure to low concentrations of thapsigargin inhibits replication of cultured human vascular smooth muscle cells
37. 2+ channel blocking activity of lacidipine and amlodipine in A7r5 vascular smooth muscle cells
38. Amlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth muscle cell proliferation
39. 2+-ATPase
40. Inhibition of tyrosine phosphorylation prevents thrombin-induced mitogenesis, but not intracellular free calcium release, in vascular smooth muscle cells
41. 2+ entry in vascular smooth muscle cells: Nicardipine-sensitive and -insensitive pathways
42. 2+ entry in vascular smooth muscle cells